Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-22T16:55:11.157Z Has data issue: false hasContentIssue false

Is household antibiotic use a risk factor for antibiotic-resistant pneumococcal infection?

Published online by Cambridge University Press:  10 January 2003

T. S. KWAN-GETT
Affiliation:
Virginia Mason Medical Center Department of Pediatrics, Seattle, WA, USA
R. L. DAVIS
Affiliation:
University of Washington Division of General Pediatrics, Seattle, WA, USA
D. K. SHAY
Affiliation:
Respiratory and Enteric Viruses Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
S. BLACK
Affiliation:
Kaiser Permanente Vaccine Study Center, Oakland, California, USA
H. SHINEFIELD
Affiliation:
Kaiser Permanente Vaccine Study Center, Oakland, California, USA
T. KOEPSELL
Affiliation:
University of Washington Department of Epidemiology, Seattle, WA, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We used microbiology and pharmacy data from health-maintenance organizations to determine whether antibiotic use by a household member increases the risk of penicillin-non-susceptible pneumococcal disease. Though it has been well established that an individual's antibiotic use increases one's risk of antibiotic-resistant infection, it is unclear whether the risk is increased if a member of one's household is exposed to antibiotics. We therefore conducted a case-control study of patients enrolled in health maintenance organizations in Western Washington and Northern California. Cases were defined as individuals with penicillin-non-susceptible pneumococcal infection; controls were individuals with penicillin-susceptible pneumococcal infection. Socioeconomic variables were obtained by linking addresses with 1997 census block group data. One-hundred and thirty-four cases were compared with 798 controls. Individual antibiotic use prior to diagnosis increased the odds of penicillin non-susceptibility, with the strongest effect seen for β-lactam use within 2 months (OR 1·8, 95% CI 1·2, 2·8). When household antibiotic use by persons other than the patient were considered, at 4 months prior to diagnosis there was a trend towards an association between penicillin non-susceptibility and β-lactam antibiotic use, and a possible association in a small subgroup of patients with eye and ear isolates. However, no significant overall pattern of association was seen. We conclude that though antibiotic use of any kind within 2 months prior to diagnosis is associated with an increased risk of penicillin-non-susceptible pneumococcal disease, there is no significant overall pattern of association between household antibiotic use and penicillin-non-susceptible pneumococcal infection.

Type
Research Article
Copyright
2002 Cambridge University Press